View Discovery

Clinical Pipeline

Trials for Market Approval Download PPT

Pre-Clinical (GLP)


iM4TB - Innovative Medicines for Tuberculosis
University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF)
Microbiotix, Inc.
GlaxoSmithKline
Global Alliance for TB Drug Development

Phase 1


LegoChem
Institute of Materia Medica
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
Otsuka Pharmaceutical Development & Commercialization, Inc.

Phase 2


Sequella, Inc
Nearmedic Plus LLC
NIAID, NIH, DHHS, Bill & Melinda Gates Foundation, EDCTP
Médecins Sans Frontières France
CDC TBTC, NIAID, NIH, DHHS, Boston University
PanACEA, EDCTP, NIAID, NIH, DHHS, USAID
Medecins Sans Frontieres, The Netherlands
Weill Medical College of Cornell University

Phase 3


Global Alliance for TB Drug Development
Médecins Sans Frontières France
Novartis
St. George's Hospital University of London
Global Alliance for TB Drug Development